JP2022033245A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022033245A5 JP2022033245A5 JP2021215368A JP2021215368A JP2022033245A5 JP 2022033245 A5 JP2022033245 A5 JP 2022033245A5 JP 2021215368 A JP2021215368 A JP 2021215368A JP 2021215368 A JP2021215368 A JP 2021215368A JP 2022033245 A5 JP2022033245 A5 JP 2022033245A5
- Authority
- JP
- Japan
- Prior art keywords
- region
- aav
- seq
- capsid protein
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662366838P | 2016-07-26 | 2016-07-26 | |
| US62/366,838 | 2016-07-26 | ||
| JP2019503445A JP6994018B2 (ja) | 2016-07-26 | 2017-07-25 | 新規アデノ随伴ウイルスキャプシドタンパク質 |
| JP2021165270A JP7395550B2 (ja) | 2016-07-26 | 2021-10-07 | 新規アデノ随伴ウイルスキャプシドタンパク質 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021165270A Division JP7395550B2 (ja) | 2016-07-26 | 2021-10-07 | 新規アデノ随伴ウイルスキャプシドタンパク質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022033245A JP2022033245A (ja) | 2022-02-28 |
| JP2022033245A5 true JP2022033245A5 (enExample) | 2022-10-19 |
| JP7303287B2 JP7303287B2 (ja) | 2023-07-04 |
Family
ID=59558468
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019503445A Expired - Fee Related JP6994018B2 (ja) | 2016-07-26 | 2017-07-25 | 新規アデノ随伴ウイルスキャプシドタンパク質 |
| JP2021165270A Active JP7395550B2 (ja) | 2016-07-26 | 2021-10-07 | 新規アデノ随伴ウイルスキャプシドタンパク質 |
| JP2021215368A Active JP7303287B2 (ja) | 2016-07-26 | 2021-12-29 | 新規アデノ随伴ウイルスキャプシドタンパク質 |
| JP2023060936A Pending JP2023076606A (ja) | 2016-07-26 | 2023-04-04 | 新規アデノ随伴ウイルスキャプシドタンパク質 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019503445A Expired - Fee Related JP6994018B2 (ja) | 2016-07-26 | 2017-07-25 | 新規アデノ随伴ウイルスキャプシドタンパク質 |
| JP2021165270A Active JP7395550B2 (ja) | 2016-07-26 | 2021-10-07 | 新規アデノ随伴ウイルスキャプシドタンパク質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023060936A Pending JP2023076606A (ja) | 2016-07-26 | 2023-04-04 | 新規アデノ随伴ウイルスキャプシドタンパク質 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US11584780B2 (enExample) |
| EP (1) | EP3491008A2 (enExample) |
| JP (4) | JP6994018B2 (enExample) |
| KR (2) | KR20230161535A (enExample) |
| CN (1) | CN109715650B (enExample) |
| AU (2) | AU2017301600B2 (enExample) |
| BR (1) | BR112019001532A2 (enExample) |
| CA (1) | CA3031026A1 (enExample) |
| CL (6) | CL2019000167A1 (enExample) |
| IL (2) | IL263801B2 (enExample) |
| MX (1) | MX2019000962A (enExample) |
| PE (1) | PE20190401A1 (enExample) |
| PH (1) | PH12019500068A1 (enExample) |
| SG (1) | SG11201811603WA (enExample) |
| WO (1) | WO2018022608A2 (enExample) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201508026D0 (en) | 2015-05-11 | 2015-06-24 | Ucl Business Plc | Capsid |
| JP7064214B2 (ja) | 2015-09-28 | 2022-05-10 | ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル | 抗体回避性ウイルスベクターのための方法および組成物 |
| CN110225975A (zh) | 2016-08-23 | 2019-09-10 | 阿库斯股份有限公司 | 用于治疗人受试者中非年龄相关的听力损害的组合物和方法 |
| MX2020008932A (es) * | 2018-02-27 | 2020-10-01 | Univ Pennsylvania | Novedosos vectores de virus adenoasociado (aav), vectores de aav que tienen una desamidacion reducida de la capside y usos de estos. |
| JP7425738B2 (ja) | 2018-04-03 | 2024-01-31 | ギンコ バイオワークス インコーポレイテッド | 眼組織を標的とするウイルスベクター |
| MX2020010464A (es) | 2018-04-03 | 2021-01-29 | Vectores de virus que evitan anticuerpos. | |
| US12091435B2 (en) | 2018-04-03 | 2024-09-17 | Ginkgo Bioworks, Inc. | Antibody-evading virus vectors |
| CA3093347A1 (en) * | 2018-04-05 | 2019-10-10 | Genethon | Hybrid recombinant adeno-associated virus serotype between aav9 and aavrh74 with reduced liver tropism |
| US12054724B2 (en) | 2018-04-10 | 2024-08-06 | President And Fellows Of Harvard College | AAV vectors encoding clarin-1 or GJB2 and uses thereof |
| JP2021522811A (ja) | 2018-05-09 | 2021-09-02 | ビオマリン プハルマセウトイカル インコーポレイテッド | フェニルケトン尿症の治療方法 |
| KR20210010491A (ko) * | 2018-05-11 | 2021-01-27 | 매사추세츠 아이 앤드 이어 인퍼머리 | 아데노-연관 바이러스의 간-특이적 향성 |
| TW202005978A (zh) * | 2018-05-14 | 2020-02-01 | 美商拜奧馬林製藥公司 | 新穎肝靶向腺相關病毒載體 |
| US11821009B2 (en) | 2018-05-15 | 2023-11-21 | Cornell University | Genetic modification of the AAV capsid resulting in altered tropism and enhanced vector delivery |
| US12195745B2 (en) | 2018-08-21 | 2025-01-14 | Massachusetts Eye And Ear Infirmary | Compositions and methods for modulating transduction efficiency of adeno-associated viruses |
| MX2021006646A (es) * | 2018-12-05 | 2021-12-10 | Abeona Therapeutics Inc | Vector viral adenoasociado recombinante para el suministro de genes. |
| WO2020154535A1 (en) * | 2019-01-23 | 2020-07-30 | University Of Florida Research Foundation, Incorporated | Highly efficient transduction and lateral spread in the retina by a novel aav virus enhanced by rational design |
| JP7698583B2 (ja) | 2019-03-21 | 2025-06-25 | ギンコ バイオワークス インコーポレイテッド | 組換えアデノ随伴ウイルスベクター |
| JP7659271B2 (ja) * | 2019-03-28 | 2025-04-09 | ザ ジェネラル ホスピタル コーポレイション | 導入遺伝子発現のための操作されたアデノ随伴（ａａｖ）ベクター |
| AR118928A1 (es) | 2019-05-14 | 2021-11-10 | Biomarin Pharm Inc | Métodos de redosificación de vectores de terapia génica |
| CN114667349A (zh) | 2019-09-09 | 2022-06-24 | 马萨诸塞眼科耳科诊所 | 用于调节腺相关病毒(aav)和aav受体(aavr)之间的相互作用以改变aav生物分布的方法和组合物 |
| EP4045664A1 (en) * | 2019-10-16 | 2022-08-24 | Wuxi Apptec (Shanghai) Co., Ltd. | A novel aav variant |
| IL292297A (en) | 2019-10-17 | 2022-06-01 | Stridebio Inc | Adeno-associated viral vectors for treatment of niemann-pick disease type c |
| CA3161154A1 (en) | 2019-11-14 | 2021-05-20 | Biomarin Pharmaceutical Inc. | Treatment of hereditary angioedema with liver-specific gene therapy vectors |
| EP4114958A1 (en) | 2020-02-21 | 2023-01-11 | Akouos, Inc. | Compositions and methods for treating non-age-associated hearing impairment in a human subject |
| TW202142554A (zh) * | 2020-02-25 | 2021-11-16 | 澳洲兒童醫學研究所 | 腺相關病毒蛋白殼多肽及載體 |
| WO2021183895A1 (en) | 2020-03-13 | 2021-09-16 | Biomarin Pharmaceutical Inc. | Treatment of fabry disease with aav gene therapy vectors |
| AR122409A1 (es) | 2020-04-03 | 2022-09-07 | Biomarin Pharm Inc | Tratamiento de la fenilcetonuria con aav y formulaciones terapéuticas |
| BR112022021134A2 (pt) | 2020-04-20 | 2023-02-14 | Tenaya Therapeutics Inc | Vírus adeno-associado com capsídeo projetado |
| WO2021222332A1 (en) | 2020-04-29 | 2021-11-04 | Bristol-Myers Squibb Company | Miniaturized dystrophins having spectrin fusion domains and uses thereof |
| WO2021236908A2 (en) | 2020-05-20 | 2021-11-25 | Biomarin Pharmaceutical Inc. | Use of regulatory proteins for the production of adeno-associated virus |
| WO2022003211A1 (en) * | 2020-07-03 | 2022-01-06 | Genethon | Method for engineering novel hybrid aav capsids through hypervariable regions swapping |
| CA3189878A1 (en) | 2020-08-19 | 2022-02-24 | Colin O'BANION | Adeno-associated virus vectors for treatment of rett syndrome |
| CA3193128A1 (en) * | 2020-09-10 | 2022-03-17 | Genethon | Peptide-modified aav capsid |
| US12129287B2 (en) | 2020-09-14 | 2024-10-29 | President And Fellows Of Harvard College | Recombinant adeno associated virus encoding clarin-1 and uses thereof |
| US20230383313A1 (en) * | 2020-10-18 | 2023-11-30 | The Trustees Of The University Of Pennsylvania | Improved adeno-associated virus (aav) vector and uses therefor |
| US20230407328A1 (en) | 2020-11-02 | 2023-12-21 | Biomarin Pharmaceutical Inc. | Process for enriching adeno-associated virus |
| WO2023034980A1 (en) | 2021-09-03 | 2023-03-09 | Bomarin Pharmaceutical Inc. | Aav capsid compositions and methods for delivery |
| EP4396201A1 (en) | 2021-09-03 | 2024-07-10 | BioMarin Pharmaceutical Inc. | Aav capsid compositions and methods for delivery |
| WO2023034990A1 (en) | 2021-09-03 | 2023-03-09 | Biomarin Pharmaceutical Inc. | Aav capsid compositions and methods for delivery |
| WO2023034997A1 (en) | 2021-09-03 | 2023-03-09 | Biomarin Pharmaceutical Inc. | Aav capsid compositions and methods for delivery |
| JP2024534894A (ja) | 2021-09-03 | 2024-09-26 | ビオマリン プハルマセウトイカル インコーポレイテッド | Ａａｖカプシド組成物及び送達方法 |
| EP4396203A1 (en) | 2021-09-03 | 2024-07-10 | BioMarin Pharmaceutical Inc. | Aav capsid compositions and methods for delivery |
| TW202332472A (zh) | 2021-10-01 | 2023-08-16 | 美商拜奧馬林製藥公司 | 利用ａａｖ基因療法載體進行之遺傳性血管水腫治療及治療性調配物 |
| CN114276419B (zh) * | 2021-12-30 | 2023-11-17 | 上海勉亦生物科技有限公司 | 肌肉高亲和性的新型腺相关病毒衣壳蛋白及其应用 |
| US20250213727A1 (en) * | 2022-03-25 | 2025-07-03 | Regenxbio Inc. | Dominant-negative tumor necrosis factor alpha adeno-associated virus gene therapy |
| TW202421788A (zh) | 2022-09-22 | 2024-06-01 | 美商拜奧馬林製藥公司 | 用ａａｖ基因療法載體治療致心律不整性心肌病 |
| TW202417631A (zh) | 2022-09-22 | 2024-05-01 | 美商拜奧馬林製藥公司 | 用ａａｖ基因治療載體治療心肌病 |
| CN115925819B (zh) * | 2022-12-30 | 2023-10-13 | 广州派真生物技术有限公司 | 腺相关病毒突变体及其应用 |
| WO2025051970A2 (en) | 2023-09-06 | 2025-03-13 | Dinaqor Ag | Methods of treatment of hypertrophic cardiomyopathy with aav gene therapy vectors and therapeutic formulations |
| WO2025054465A1 (en) * | 2023-09-08 | 2025-03-13 | California Institute Of Technology | Compositions for transport of therapeutic cargos using miniprotein binders targeting ca-iv |
| WO2025104321A1 (en) * | 2023-11-17 | 2025-05-22 | Genethon | Prediction of multiple aav properties by deep learning |
| WO2025214477A1 (en) | 2024-04-12 | 2025-10-16 | Skyline Therapeutics (Shanghai) Co., Ltd. | Treatment of genetic cardiomyopathies with aav gene therapy vectors |
| WO2025250683A1 (en) * | 2024-05-29 | 2025-12-04 | Tenaya Therapeutics, Inc. | Adeno-associated virus with engineered capsid |
Family Cites Families (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0127839B1 (en) | 1983-05-27 | 1992-07-15 | THE TEXAS A&M UNIVERSITY SYSTEM | Method for producing a recombinant baculovirus expression vector |
| US4745051A (en) | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
| ZA848495B (en) | 1984-01-31 | 1985-09-25 | Idaho Res Found | Production of polypeptides in insect cells |
| US4994371A (en) | 1987-08-28 | 1991-02-19 | Davie Earl W | DNA preparation of Christmas factor and use of DNA sequences |
| US6204059B1 (en) | 1994-06-30 | 2001-03-20 | University Of Pittsburgh | AAV capsid vehicles for molecular transfer |
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| RU2273645C9 (ru) | 1994-08-17 | 2006-11-27 | Дзе Рокефеллер Юниверсити | Полипептид ожирения (ов)(варианты), его аналог (варианты) и слитый белок (варианты), изолированная молекула нуклеиновой кислоты, молекула днк, рекомбинантный вектор клонирования, рекомбинантный вектор экспрессии, фармацевтическая композиция, моноклональное и поликлональное антитело |
| EP0931158A1 (en) | 1996-09-06 | 1999-07-28 | The Trustees Of The University Of Pennsylvania | An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
| US6521225B1 (en) | 1996-09-06 | 2003-02-18 | Chiron Corporation | AAV vectors |
| WO1999003496A1 (en) | 1997-07-21 | 1999-01-28 | The University Of North Carolina At Chapel Hill | Factor ix antihemophilic factor with increased clotting activity |
| DK1071752T3 (da) | 1998-04-21 | 2003-10-20 | Micromet Ag | CD19xCD3-specifikke polypeptider og anvendelsen deraf |
| JP2004514407A (ja) | 2000-04-28 | 2004-05-20 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 異種キャプシド中にシュードタイピングされたａａｖ５キャプシドおよびａａｖ５ベクターを含む組換えａａｖベクター |
| DK1447448T3 (da) | 2001-10-16 | 2011-05-02 | Nat Inst Of Advanced Ind Scien | Ny N-acetylglucosamin-transferase, kodende nukleinsyre for den samme, antistof mod den samme og anvendelser deraf til diagnosticering af cancer eller tumor |
| US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
| CN103555677B (zh) | 2001-11-13 | 2018-01-30 | 宾夕法尼亚大学托管会 | 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法 |
| PT2573170T (pt) | 2001-12-17 | 2018-03-26 | Univ Pennsylvania | Sequências de um vírus adenoassociado (aav) de serotipo 9, vetor contendo as mesmas, e suas utilizações |
| WO2003074714A1 (en) | 2002-03-05 | 2003-09-12 | Stichting Voor De Technische Wetenschappen | Baculovirus expression system |
| US20030198620A1 (en) | 2002-04-16 | 2003-10-23 | Keiya Ozawa | Method of treating amino acid metabolic disorders using recombinant adeno-associated virus virions |
| AU2003237159A1 (en) | 2002-04-30 | 2003-11-17 | University Of Florida | Treatment for phenylketonuria |
| DK3211085T3 (da) | 2003-09-30 | 2021-06-21 | Univ Pennsylvania | Klader af adeno-associeret virus (aav), sekvenser, vektorer indeholdende disse og anvendelser deraf |
| JP5184783B2 (ja) | 2003-11-17 | 2013-04-17 | バイオマリン ファーマシューティカル インコーポレイテッド | テトラヒドロビオプテリン、及びテトラヒドロビオプテリン類似体の製造方法 |
| EP1771571A2 (en) | 2004-07-30 | 2007-04-11 | Targeted Genetics Corporation | Recombinant aav based vaccine methods |
| WO2006055511A2 (en) | 2004-11-17 | 2006-05-26 | Biomarin Pharmaceutical Inc. | Stable tablet formulation of tetrahydrobiopterin |
| US8999678B2 (en) | 2005-04-07 | 2015-04-07 | The Trustees Of The University Of Pennsylvania | Method of increasing the function of an AAV vector |
| WO2006119432A2 (en) * | 2005-04-29 | 2006-11-09 | The Government Of The U.S.A., As Rep. By The Sec., Dept. Of Health & Human Services | Isolation, cloning and characterization of new adeno-associated virus (aav) serotypes |
| US7531341B1 (en) | 2006-06-12 | 2009-05-12 | Biomarin Pharmaceutical Inc. | Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof |
| US7534595B2 (en) | 2006-06-12 | 2009-05-19 | Biomarin Pharmaceutical Inc. | Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof |
| WO2008088895A2 (en) | 2007-01-18 | 2008-07-24 | University Of Missouri-Columbia | Synthetic mini/micro-dystrophin genes to restore nnos to the sarcolemma |
| AR066354A1 (es) | 2007-05-01 | 2009-08-12 | Genzyme Corp | La terapia sistematica con factor-1 de crecimiento de tipo insulina reduce la neuropatia periferica diabetica y mejora la funcion renal en la nefropatia diabetica |
| DK3093345T3 (da) * | 2007-07-26 | 2019-06-24 | Uniqure Ip Bv | Baculovirusvektorer omfattende gentagne kodende sekvenser med differentielle foretrukne kodoner |
| US7560263B2 (en) | 2007-08-17 | 2009-07-14 | Biomarin Pharmaceutical Inc. | Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof |
| CA2711444C (en) | 2008-01-07 | 2017-12-12 | Biomarin Pharmaceutical Inc. | Method of synthesizing tetrahydrobiopterin |
| NZ600979A (en) | 2008-01-15 | 2014-01-31 | Abbott Lab | Improved mammalian expression vectors and uses thereof |
| US7943379B2 (en) | 2008-04-30 | 2011-05-17 | Nationwide Children's Hospital, Inc. | Production of rAAV in vero cells using particular adenovirus helpers |
| WO2010014225A2 (en) | 2008-07-30 | 2010-02-04 | Biomarin Pharmaceutical Inc. | Assays for detection of phenylalanine ammonia-lyase and antibodies to phenylalanine ammonia-lyase |
| EP2337849B1 (en) | 2008-09-15 | 2018-06-13 | uniQure biopharma B.V. | Factor ix polypeptide mutant, its uses and a method for its production |
| ES2724122T3 (es) | 2009-04-30 | 2019-09-06 | Univ Pennsylvania | Composiciones para dirigir células de las vías respiratorias de conducción que comprenden construcciones de virus adenoasociado |
| GB0911870D0 (en) | 2009-07-08 | 2009-08-19 | Ucl Business Plc | Optimised coding sequence and promoter |
| CN103038343A (zh) | 2010-03-23 | 2013-04-10 | 英特瑞克斯顿股份有限公司 | 条件表达治疗蛋白的载体，包含所述载体的宿主细胞，及其应用 |
| SG10201908848RA (en) | 2010-03-29 | 2019-10-30 | Univ Pennsylvania | Pharmacologically induced transgene ablation system |
| FR2977562B1 (fr) | 2011-07-06 | 2016-12-23 | Gaztransport Et Technigaz | Cuve etanche et thermiquement isolante integree dans une structure porteuse |
| WO2013123503A1 (en) | 2012-02-17 | 2013-08-22 | The Children's Hospital Of Philadelphia | Aav vector compositions and methods for gene transfer to cells, organs and tissues |
| GB201210357D0 (en) | 2012-06-12 | 2012-07-25 | Ucl Business Plc | Factor VIII sequences |
| SG10201707319UA (en) | 2013-03-15 | 2017-10-30 | Univ Pennsylvania | Compositions and methods for treating mpsi |
| CA2907799A1 (en) | 2013-05-31 | 2014-12-04 | The Regents Of The University Of California | Adeno-associated virus variants and methods of use thereof |
| CA3209883A1 (en) * | 2013-07-22 | 2015-01-29 | The Children's Hospital Of Philadelphia | Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues |
| ES2813698T3 (es) | 2013-09-12 | 2021-03-24 | Biomarin Pharm Inc | Vectores de AAV que comprenden un gen que codifica el factor VIII |
| ES2857751T3 (es) * | 2013-10-11 | 2021-09-29 | Massachusetts Eye & Ear Infirmary | Métodos para predecir secuencias de virus ancestrales y usos de los mismos |
| EA201992208A1 (ru) | 2013-10-22 | 2020-07-31 | Транслейт Био, Инк. | ЛЕЧЕНИЕ ФЕНИЛКЕТОНУРИИ С ПРИМЕНЕНИЕМ мРНК |
| WO2015138357A2 (en) | 2014-03-09 | 2015-09-17 | The Trustees Of The University Of Pennsylvania | Compositions useful in treatment of otc deficency |
| EP2960336A1 (en) | 2014-06-27 | 2015-12-30 | Genethon | Efficient systemic treatment of dystrophic muscle pathologies |
| CN106456547B (zh) | 2014-07-02 | 2021-11-12 | 川斯勒佰尔公司 | 信使rna的包封 |
| US10301367B2 (en) | 2014-07-26 | 2019-05-28 | Consiglio Nazionale Delle Ricerche | Compositions and methods for treatment of muscular dystrophy |
| KR20230067694A (ko) | 2014-09-24 | 2023-05-16 | 시티 오브 호프 | 고효율 게놈 편집을 위한 아데노-관련 바이러스 벡터 변이체 및 이의 방법 |
| GB201507842D0 (en) | 2015-05-07 | 2015-06-17 | New Royal Holloway & Bedford | Production of large-sized microdystrophins in an AAV-based vector configuration |
| CA2994160C (en) * | 2015-07-30 | 2021-08-10 | Massachusetts Eye And Ear Infirmary | Ancestral virus sequences and uses thereof |
| BR112018006074A2 (pt) | 2015-09-24 | 2018-10-09 | Biomarin Pharm Inc | vetores de fator viii de vírus adeno-associado, partículas virais associadas e formulações terapêuticas compreendendo as mesmas |
| WO2017066764A2 (en) | 2015-10-16 | 2017-04-20 | William Marsh Rice University | Modification of n-terminal region of capsid proteins for enhanced properties of adeno-associated viruses |
| KR102766526B1 (ko) | 2015-10-28 | 2025-02-13 | 상가모 테라퓨틱스, 인코포레이티드 | 간-특이적 작제물인, 인자 viii 발현 카세트 및 이의 사용 방법 |
| PE20231949A1 (es) | 2015-10-30 | 2023-12-05 | Spark Therapeutics Inc | VARIANTES DEL FACTOR VIII REDUCIDO CON CpG, COMPOSICIONES Y METODOS Y USOS PARA EL TRATAMIENTO DE TRASTORNOS DE LA HEMOSTASIA |
| IL266264B2 (en) | 2016-11-04 | 2023-11-01 | Baxalta Inc | Adeno-associated virus formulations |
| EP3562494A4 (en) | 2016-12-30 | 2020-08-19 | The Trustees Of The University Of Pennsylvania | GENE THERAPY FOR THE TREATMENT OF PHENYLKETONURIS |
| US10610606B2 (en) | 2018-02-01 | 2020-04-07 | Homology Medicines, Inc. | Adeno-associated virus compositions for PAH gene transfer and methods of use thereof |
| PE20210341A1 (es) | 2018-02-01 | 2021-02-23 | Homology Medicines Inc | Composiciones de virus adeno-asociadas para la transferencia de genes pah y metodos de uso de los mismos |
| JP2021522811A (ja) | 2018-05-09 | 2021-09-02 | ビオマリン プハルマセウトイカル インコーポレイテッド | フェニルケトン尿症の治療方法 |
| AR117427A1 (es) | 2018-05-14 | 2021-08-04 | Biomarin Pharm Inc | Expresión estable de vectores de aav en sujetos jóvenes |
| TW202005978A (zh) | 2018-05-14 | 2020-02-01 | 美商拜奧馬林製藥公司 | 新穎肝靶向腺相關病毒載體 |
| MX2021000810A (es) | 2018-07-24 | 2021-04-28 | Voyager Therapeutics Inc | Sistemas y metodos para producir formulaciones de terapia genetica. |
| JP7630443B2 (ja) | 2019-04-19 | 2025-02-17 | レジェンクスバイオ インコーポレーテッド | アデノ随伴ウイルスベクター製剤及び方法 |
| AR118928A1 (es) | 2019-05-14 | 2021-11-10 | Biomarin Pharm Inc | Métodos de redosificación de vectores de terapia génica |
| AR122409A1 (es) | 2020-04-03 | 2022-09-07 | Biomarin Pharm Inc | Tratamiento de la fenilcetonuria con aav y formulaciones terapéuticas |
-
2017
- 2017-07-25 IL IL263801A patent/IL263801B2/en unknown
- 2017-07-25 SG SG11201811603WA patent/SG11201811603WA/en unknown
- 2017-07-25 CN CN201780045741.3A patent/CN109715650B/zh active Active
- 2017-07-25 US US16/319,877 patent/US11584780B2/en active Active
- 2017-07-25 IL IL305149A patent/IL305149A/en unknown
- 2017-07-25 EP EP17749265.9A patent/EP3491008A2/en active Pending
- 2017-07-25 MX MX2019000962A patent/MX2019000962A/es unknown
- 2017-07-25 CA CA3031026A patent/CA3031026A1/en active Pending
- 2017-07-25 KR KR1020237039466A patent/KR20230161535A/ko not_active Abandoned
- 2017-07-25 JP JP2019503445A patent/JP6994018B2/ja not_active Expired - Fee Related
- 2017-07-25 KR KR1020197001930A patent/KR102604510B1/ko active Active
- 2017-07-25 BR BR112019001532A patent/BR112019001532A2/pt unknown
- 2017-07-25 AU AU2017301600A patent/AU2017301600B2/en not_active Ceased
- 2017-07-25 WO PCT/US2017/043703 patent/WO2018022608A2/en not_active Ceased
- 2017-07-25 PE PE2019000266A patent/PE20190401A1/es unknown
-
2019
- 2019-01-10 PH PH12019500068A patent/PH12019500068A1/en unknown
- 2019-01-22 CL CL2019000167A patent/CL2019000167A1/es unknown
-
2020
- 2020-12-04 CL CL2020003176A patent/CL2020003176A1/es unknown
-
2021
- 2021-10-07 JP JP2021165270A patent/JP7395550B2/ja active Active
- 2021-12-29 JP JP2021215368A patent/JP7303287B2/ja active Active
-
2022
- 2022-10-27 AU AU2022259813A patent/AU2022259813A1/en not_active Abandoned
- 2022-12-08 US US18/063,589 patent/US20230322864A1/en not_active Abandoned
-
2023
- 2023-01-18 CL CL2023000165A patent/CL2023000165A1/es unknown
- 2023-04-04 JP JP2023060936A patent/JP2023076606A/ja active Pending
- 2023-09-15 CL CL2023002764A patent/CL2023002764A1/es unknown
- 2023-10-06 CL CL2023003001A patent/CL2023003001A1/es unknown
- 2023-10-06 CL CL2023003010A patent/CL2023003010A1/es unknown
-
2024
- 2024-05-28 US US18/676,309 patent/US20240317813A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022033245A5 (enExample) | ||
| JP2023076606A5 (enExample) | ||
| JP2022001064A5 (enExample) | ||
| JP7416443B2 (ja) | 高形質導入効率ｒＡＡＶベクター、組成物、および使用方法 | |
| JP6387350B2 (ja) | 希突起神経膠細胞を標的とするアデノ随伴ウイルスベクター | |
| JP7237843B2 (ja) | 修飾されたａａｖキャプシドタンパク質およびその使用 | |
| JP2024045227A (ja) | パルボウイルスベクターの高められた送達のための改変キャプシドタンパク質 | |
| JP7444521B2 (ja) | 臨床使用に適した無血清懸濁細胞培養システムにおいて組換えアデノ随伴ウイルス（ａａｖ）ベクターを産生するスケーラブルな方法 | |
| JP4860886B2 (ja) | 二本鎖パルボウイルスベクター | |
| JP2017536116A5 (enExample) | ||
| WO2017192750A1 (en) | Recombinant adeno-associated viral vectors | |
| CN115960921B (zh) | 一组肝靶向新型腺相关病毒的获得及其应用 | |
| US20230159950A1 (en) | Methods and compositions for production of recombinant adeno-associated viruses | |
| CN110691846A (zh) | 合理的多倍体腺相关病毒载体及其制造和使用方法 | |
| CN117624311A (zh) | 可提高aav病毒神经靶向性的衣壳蛋白突变体及其应用 | |
| WO2024184781A1 (en) | Engineered aav capsids | |
| WO2025065890A1 (zh) | 一种重组腺相关病毒颗粒、重组腺相关病毒载体系统及其应用 | |
| Lv et al. | Design Strategies of Adeno-Associated Virus (AAV) Vectors in Gene Therapy | |
| EP4444894A1 (en) | Methods and systems for transfecting host cells | |
| Shen et al. | Significant Enhancement of Adeno‐Associated Virus Vector Yield for Gene Therapy Using Multidimensional Optimization Strategies | |
| TW202542307A (zh) | 末端封閉的ｄｎａ的可規模化生產 | |
| TW202507001A (zh) | 改善rAAV生產之方法 | |
| CN117886898A (zh) | 腺相关病毒变体及其应用 | |
| CN120209091A (zh) | 靶向肝细胞的重组aav衣壳蛋白及其应用 | |
| KR20240002094A (ko) | Aav 벡터 생산을 위한 배큘로바이러스 감염 세포 스탁 및 aav 벡터의 제조방법 |